Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
Titel:
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
Auteur:
Granit, Volkan Benatar, Michael Kurtoglu, Metin Miljković, Miloš D Chahin, Nizar Sahagian, Gregory Feinberg, Marc H Slansky, Adam Vu, Tuan Jewell, Christopher M Singer, Michael S Kalayoglu, Murat V Howard Jr, James F Mozaffar, Tahseen